Yahoo Canada Web Search

Search results

  1. www.pro.novartis.ca › en › authentication| Pro.Novartis.ca

    You are a few seconds away from discovering the Novartis Pro Portal! Register with your e-mail address.

  2. www.pro.novartis.ca › en › authenticationLogin - Pro.Novartis.ca

    ©2024 Novartis Pharma Canada inc. This site is intended for an HCP audience in Canada.

  3. NVS - Novartis AG

    Yahoo Finance

    113.77-0.09 (-0.08%)

    at Tue, Oct 8, 2024, 4:00PM EDT - U.S. markets closed

    After Hours 114.46 +0.69 (+0.61%)

    Delayed Quote

    • Open 114.12
    • High 114.19
    • Low 113.55
    • Prev. Close 113.86
    • 52 Wk. High 120.92
    • 52 Wk. Low 92.19
    • P/E 23.31
    • Mkt. Cap 230.34B
  4. Phone: 1-877-631-6775. Fax: 1-877-636-3175. Email: drug.safety@novartis.com. For any technical inquiries relating to the Novartis Pro Portal, including account access issues, password reset requests, or other technical questions, please contact our Novartis Pro Portal support team at portal.support@novartis.com.

  5. Medical Information. Phone : 1-800-363-8883 Email : medinfo.canada@novartis.com Patient Safety & Pharmacovigilance Phone : 1-877-631-6775 Fax : 1-877-636-3175 Email : drug.safety@novartis.com.

  6. ©2024 Novartis Pharma Canada inc. This site is intended for an HCP audience in Canada.

  7. Mot de passe oublié? Vous quittez maintenant le site pro.novartis.ca. Ce lien vous redirigera vers un site pour lequel notre Avis de confidentialité ne s’applique pas. Vous êtes entièrement responsable de vos actions sur ce site. Ce site est destiné aux professionnels de la santé du Canada.

  8. Sep 28, 2023 · This Privacy Notice (“Notice”) contains practical information about the specific personal information we process when you visit our website Novartis Pro Portal, why we process this information and how.

  9. ©2024 Novartis Pharma Canada inc. This site is intended for an HCP audience in Canada.

  10. ©2024 Novartis Pharma Canada inc. This site is intended for an HCP audience in Canada.

  11. ©2024 Novartis Pharmaceuticals Canada Inc. All rights reserved. This site is intended for an HCP audience in Canada.

  1. People also search for